Reporting to the CEO, with overall accountability for software product road map, IT security, and engineering team line management at innovative precision medicine drug development and healthcare data analytics company. Specialist role as real world evidence (RWE) project champion and data engineer.

Senior leadership role in growing oncology data sharing network, connecting cancer centers across Europe in near-real time, to deliver insights and accelerate research in treatment best practice, variation in care, and financial sustainability to multiple stakeholders. Key responsibilities:• Technology team lead, accountable for solution and data architecture road maps, information governance and costs for deployment of oncology research data repositories, including automated pseudonymous ingest (ETL) from source systems• Product lead and scrum product owner responsible for agile design and build of analytic dashboards for member healthcare organisations via secure external portal.• Stakeholder engagement, supporting value proposition to prospective network member healthcare organisations.• Recruitment, mentoring and resource allocation of distributed technical teams.

Technology lead and principal consultant accountable for software product road map, AI/ML workflow automation, development team and IT services at innovative healthcare data analytics and precision medicine services company. Reporting to the CEO, major responsibilities included:• Real World Insights: principal consultant, data architect and advocate for client projects in health economics and outcomes research• Oncology: product manager for Onco KEM, a personalized treatment selection system for oncologists; technical contact for WINTHER precision medicine clinical trial, working closely with trial IT, clinical data manager and oncologists on data quality and preliminary analysis of treatment decisions• Project and line management of software engineering team developing association rule-based data mining and predictive analytics tools (KEM platform). Driver of transformation of KEM from standalone desktop application to open data science framework (KNIME). Architect and lead developer of visual data and rule network explorer (KEM Query).• IT services management• Investor, client/partner and conference presentations; recruitment; marketing support.

Launched independent consultancy to help clients transform innovative computational science into robust technology platforms. Key client projects:• (Ariana Pharma) Interim CTO. Led first commercial releases of KEM machine learning application for clinical trial data analysis (Java).• (GSK) Developed GUI optimization app for compound collection design (Java).• (Vernalis) Enhancement and maintenance of rDock virtual screening software and conversion to open source package (C++)• (Hyde Park Global Investments) Interim CTO for US hedge fund. Architect of production trading and simulation platform integrating live market data sources, streaming analytics and machine learning. R&D of automated news sentiment-based trading strategies (C++, Java).

Recruited and led Computational Technology team of informaticians, computer scientists and software engineers. Worked closely with key internal stakeholders across IT, structural sciences, chemistry and biology to deliver innovative tools, databases, workflows, and predictive analytic models (docking, ADME/T properties) to support in-house structure-based drug discovery programs.Technology presentations to investors, Scientific Advisory Board, and scientific conferences.

Joined RiboTargets biotech startup as their first computational chemist, and was responsible for bootstrapping all aspects of the implementation (architecture, design, development) of high performance virtual screening tools for structure-based drug discovery (RiboDock/rDock), The platform had a major influence on company strategy during early growth phase, and has since been made available to the community as an open source tool.Project manager for collaboration with Sun Microsystems to conduct massive virtual screening campaign against bacterial ribosome using distributed grid technology.